1258
Vol. 58, No. 9
243.0838.
References
6-Chloro-8-(3-methoxyphenyl)-1,2,3,4-tetrahydroquinoline (5b) The
1) Schröter S., Stock C., Bach T., Tetrahedron, 61, 2245—2267 (2005).
2) Fairlamb I. J. S., Chem. Soc. Rev., 36, 1036—1045 (2007).
3) Wang J.-R., Manabe K., Synthesis, 1405—1427 (2009).
4) Ishikawa S., Manabe K., Org. Lett., 9, 5593—5595 (2007).
5) Manabe K., Ishikawa S., Synthesis, 2645—2649 (2008).
6) Ishikawa S., Manabe K., Synthesis, 3180—3182 (2008).
7) Sundberg R. J., “Comprehensive Heterocyclic Chemistry II,” Vol. 2,
ed. by Katritzky A. R., Ress C. W., Scriven E. F. V., Bird C. W., Perga-
mon Press, Oxford, 1996, pp. 119—206.
reaction was performed with 1c (57.6 mg, 0.285 mmol) and a 1 M solution of
3-methoxyphenylmagnesium bromide in THF (0.855 ml, 0.855 mmol). Pu-
rification by preparative TLC (hexane : AcOEtϭ9 : 1, developed twice) af-
forded 5b (59.6 mg, 0.218 mmol, 76%) as a yellow-white solid. mp 88—
92 °C. 1H-NMR (CDCl3) d: 1.91—1.95 (2H, m), 2.80 (2H, t, Jϭ6.5 Hz),
3.24 (2H, t, Jϭ5.7 Hz), 3.84 (3H, s), 4.09 (1H, br), 6.88—6.93 (4H, m), 6.96
(1H, d, Jϭ7.9 Hz), 7.34 (1H, t, Jϭ7.9 Hz). 13C-NMR (CDCl3) d: 21.6, 27.4,
41.8, 55.3, 113.1, 114.6, 120.5, 121.4, 122.7, 127.3, 127.4, 128.2, 130.0,
139.7, 140.2, 160.0. IR (ATR): 3406, 2930, 1585, 1485, 1462, 1356, 1290,
1227, 1034, 864, 781, 702 cmϪ1. HR-MS (ESI): Calcd for C16H16ClNO
(M)ϩ 273.0915, Found 273.0913.
8) Gribble G. W., “Comprehensive Heterocyclic Chemistry II,” Vol. 2, ed.
by Katritzky A. R., Ress C. W., Scriven E. F. V., Bird C. W., Pergamon
Press, Oxford, 1996, pp. 207—258.
6-Chloro-8-(2-thienyl)-1,2,3,4-tetrahydroquinoline (5c) The reaction
was performed with 1c (59.0 mg, 0.292 mmol) and a 1 M solution of 2-
thienylmagnesium bromide in THF (0.876 mg, 0.876 mmol). Purification by
preparative TLC (hexane : AcOEtϭ5 : 1) afforded 5c (55.6 mg, 0.223 mmol,
9) Kawasaki T., Higuchi K., Nat. Prod. Rep., 22, 761—793 (2005).
10) Somei M., Yamada F., Nat. Prod. Rep., 22, 73—103 (2005).
11) Katritzky A. R., Rachwal S., Rachwal B., Tetrahedron, 52, 15031—
15070 (1996).
77%) as a yellow oil. 1H-NMR (CDCl3) d: 1.91—1.96 (2H, m), 2.79 (2H, t, 12) Bartoli G., Palmieri G., Tetrahedron Lett., 30, 2129—2132 (1989).
Jϭ6.2 Hz), 3.29 (2H, t, Jϭ6.2 Hz), 4.46 (1H, br), 6.93 (1H, d, Jϭ2.3 Hz),
7.04 (1H, d, Jϭ2.3 Hz), 7.10—7.11 (1H, m), 7.13—7.14 (1H, m), 7.35 (1H,
13) Teng X., Degterev A., Jagtap P., Xing X., Choi S., Denu R., Yuan J.,
Cuny G. D., Bioorg. Med. Chem. Lett., 15, 5039—5044 (2005).
dd, Jϭ5.1, 1.1 Hz). 13C-NMR (CDCl3) d: 21.4, 27.4, 41.8, 119.7, 120.4, 14) Nomura S., Yamamoto Y., WO 2006080577 (2006) [PCT Int. Appl.].
123.0, 125.6, 126.3, 127.5, 128.2, 128.8, 139.6, 141.0. IR (ATR): 3418, 15) Su D.-S., Anthony N. J., Lim J. J., Tinney E., Williams T. M., WO
2928, 2837, 1489, 1439, 1425, 1354, 1287, 1190, 851 cmϪ1. HR-MS (ESI):
Calcd for C13H12ClNS (M)ϩ 249.0373, Found 249.0381.
2007146230 A2 (2007) [PCT Int. Appl.].
16) Activation of C–X bonds by coordination to Mg has been reported.
See: Terao J., Ikumi A., Kuniyasu H., Kambe N., J. Am. Chem. Soc.,
125, 5646—5647 (2003).
6-Chloro-8-(2-methylprop-1-en-1-yl)-1,2,3,4-tetrahydroquinoline (5d)
The reaction was performed with 1c (55.0 mg, 0.272 mmol) and a 0.5 M solu-
tion of 2-methylpropen-1-ylmagnesium bromide in THF (1.63 ml, 17) Yoshikai N., Mashima H., Nakamura E., J. Am. Chem. Soc., 127,
0.816 mmol). Purification by preparative TLC (hexane : AcOEtϭ7 : 1) af-
17978—17979 (2005).
18) Saeki T., Takashima Y., Tamao K., Synlett, 1771—1774 (2005).
forded 5d (31.7 mg, 0.143 mmol, 53%) as a yellow oil. 1H-NMR (CDCl3) d:
1.72 (3H, d, Jϭ1.1 Hz), 1.90 (3H, d, Jϭ1.1 Hz), 1.91—1.94 (2H, m), 2.75 19) Fairlamb I. J. S., O’Brien C. T., Linb Z., Lam K. C., Org. Biomol.
(2H, t, Jϭ6.5 Hz), 3.32 (2H, t, Jϭ6.5 Hz), 3.83 (1H, br), 5.88 (1H, s), 6.78
(1H, d, Jϭ2.3 Hz), 6.82 (1H, d, Jϭ2.3 Hz). 13C-NMR (CDCl3) d: 19.4, 21.7,
26.0, 27.2, 41.9, 119.8, 120.1, 122.2, 124.4, 127.0, 127.1, 138.4, 140.8. IR
(ATR): 3426, 2928, 2853, 1489, 1447, 1352, 1292, 1179, 1070, 880,
Chem., 4, 1213—1216 (2006).
20) Handy S. T., Zhang Y., Chem. Commun., 299—301 (2006).
21) Legault C. Y., Garcia Y., Merlic C. A., Houk K. N., J. Am. Chem. Soc.,
129, 12664—12665 (2007).
866 cmϪ1. HR-MS (ESI): Calcd for C13H16ClN (M)ϩ 221.0966, Found 22) Garcia Y., Schoenebeck F., Legault C. Y., Merlic C. A., Houk K. N., J.
221.0975. Am. Chem. Soc., 131, 6632—6639 (2009).
Experimental Procedure for a Competitive Reaction of Compounds 6 23) Schaub T., Fischer P., Steffen A., Braun T., Radius U., Mix A., J. Am.
and 7 To a solution of 7-chloroindole (6) (71.0 mg, 0.468 mmol), 5-
chloroindole (7) (71.0 mg, 0.468 mmol) and PdCl2(PCy3)2 (17.3 mg,
0.0234 mmol, 5 mol%) in THF (0.125 M) was slowly added 4-
methoxyphenylmagnesium bromide (0.5 M in THF, 3.74 ml, 1.87 mmol, 4 eq)
at 0 °C. The resulting mixture was stirred at 0 °C for 30 min and then at
70 °C for 18 h. The reaction was quenched with a saturated NH4Cl aqueous
solution. After AcOEt was added, the layers were separated, and the aqueous
layer was extracted with AcOEt. Combined organic phase was washed with
brine and dried over anhydrous Na2SO4. After filtration, all volatiles were
evaporated, and the crude mixture was analyzed by 1H-NMR spectra with
comparison to literature data25) to obtain yields of products 8 and 9.
Chem. Soc., 130, 9304—9317 (2008).
24) Shaffer C. L., Morton M. D., Hanzlik R. P., J. Am. Chem. Soc., 123,
8502—8508 (2001).
25) Prieto M., Zurita E., Rosa E., Munoz L., Williams L. P., Giralt E., J.
Org. Chem., 69, 6812—6820 (2004).
26) Kong J., White C. A., Krylov A. I., Sherrill C. D., Adamson R. D.,
Furlani T. R., Lee M. S., Lee A. M., Gwaltney S. R., Adams T. R.,
Ochsenfeld C., Gilbert A. T. B., Kedziora G. S., Rassolov V. A., Mau-
rice D. R., Nair N., Shao Y., Besley N. A., Maslen P. E., Dombroski J.
P., Daschel H., Zhang W., Korambath P. P., Baker J., Byrd E. F. C., Van
Voorhis T., Oumi M., Hirata S., Hsu C.-P., Ishikawa N., Florian J.,
Warshel A., Johnson B. G., Gill P. M. W., Head-Gordon M., Pople J.
A., J. Computational Chem., 21, 1532—1548 (2000).
Computational Analysis All the molecular calculations were per-
formed with Spartan ’04.26) Geometry optimizations in the gas phase were
carried out with the B3LYP/6-31G(d) DFT method.27,28)
27) Kohn W., Becke A. D., Parr R. G., J. Phys. Chem., 100, 12974—12980
(1996).
Acknowledgment We thank Takeda Science Foundation for financial 28) Becke A. D., J. Chem. Phys., 98, 5648—5652 (1993).
support.